Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-11 5:47 pm Sale | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | L1 Capital Global Opportunities Master Fund, Ltd. | 700 11.000% | -5,967 (-89.50%) | Filing History |
| 2022-02-11 5:01 pm Sale | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | Lind Global Macro Fund LP | 244 0.200% | -3,506 (-93.49%) | Filing History |
| 2022-02-11 08:00 am Sale | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | Lynwood Capital Management Inc. | 5,233 4.920% | -633 (-10.80%) | Filing History |
| 2022-02-04 4:35 pm Sale | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | BIGGER CAPITAL FUND L P | 1,000 11.000% | -13,900 (-93.29%) | Filing History |
| 2022-01-20 09:47 am Sale | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | Empery Asset Management, LP | 3,333 2.520% | -76 (-2.23%) | Filing History |
| 2022-01-03 7:24 pm Purchase | 2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX | SABBY MANAGEMENT, LLC | 5,046 11.000% | 1,346 (+36.38%) | Filing History |
| 2021-09-20 5:25 pm Sale | 2021-09-16 | 13D | BriaCell Therapeutics Corp. BCTX | Hyperscale Data Inc. GPUS | 4,767 4.670% | -1,133 (-19.21%) | Filing History |
| 2021-09-13 08:30 am Purchase | 2021-09-02 | 13G | BriaCell Therapeutics Corp. BCTX | K.J. Harrison & Partners Inc | 6,399 6.230% | 6,399 (New Position) | Filing History |
| 2021-09-07 4:05 pm Unchanged | 2021-09-01 | 13D | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 10,200 10.000% | 0 (Unchanged) | Filing History |
| 2021-08-17 4:04 pm Purchase | 2021-08-09 | 13G | BriaCell Therapeutics Corp. BCTX | Lynwood Capital Management Inc. | 5,867 5.800% | 5,867 (New Position) | Filing History |
| 2021-08-09 06:01 am Purchase | 2021-08-06 | 13D | BriaCell Therapeutics Corp. BCTX | Hyperscale Data Inc. GPUS | 5,900 6.150% | 5,900 (New Position) | Filing History |
| 2021-08-04 09:43 am Purchase | 2021-08-03 | 13G | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 10,200 10.000% | 5,367 (+111.03%) | Filing History |
| 2021-06-28 4:15 pm Purchase | 2021-06-21 | 13G | BriaCell Therapeutics Corp. BCTX | L5 Capital Inc. | 4,833 5.010% | 4,833 (New Position) | Filing History |
| 2021-06-14 1:14 pm Purchase | 2021-06-03 | 13G | BriaCell Therapeutics Corp. BCTX | CVI Investments, Inc. | 4,000 5.000% | 4,000 (New Position) | Filing History |
| 2021-03-08 4:16 pm Purchase | 2021-02-24 | 13G | BriaCell Therapeutics Corp. BCTX | Altium Capital Management LLC | 3,333 8.900% | 3,333 (New Position) | Filing History |
| 2021-03-05 4:13 pm Purchase | 2021-02-26 | 13G | BriaCell Therapeutics Corp. BCTX | L1 Capital Global Opportunities Master Fund, Ltd. | 6,667 16.300% | 6,667 (New Position) | Filing History |
| 2021-03-03 07:43 am Purchase | 2021-02-24 | 13G | BriaCell Therapeutics Corp. BCTX | SABBY MANAGEMENT, LLC | 3,700 11.000% | 3,700 (New Position) | Filing History |
| 2021-03-02 12:06 pm Purchase | 2021-02-23 | 13G | BriaCell Therapeutics Corp. BCTX | Empery Asset Management, LP | 3,409 8.890% | 3,409 (New Position) | Filing History |
| 2021-02-26 5:02 pm Purchase | 2021-02-26 | 13G | BriaCell Therapeutics Corp. BCTX | Lind Global Macro Fund LP | 3,751 9.900% | 3,751 (New Position) | Filing History |
| 2021-02-26 09:02 am Purchase | 2021-02-23 | 13G | BriaCell Therapeutics Corp. BCTX | BIGGER CAPITAL FUND L P | 14,900 9.800% | 14,900 (New Position) | Filing History |